Ameluz

Active Ingredient(s): Aminolevulinic Acid Hydrochloride
FDA Approved: * May 10, 2016
Pharm Company: * BIOFRONTERA PHARMA AG
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Ameluz Overview

δ-Aminolevulinic acid (also dALA, δ-ALA, 5ALA or 5-aminolevulinic acid), an endogenous non-proteinogenic amino acid, is the first compound in the porphyrin synthesis pathway, the pathway that leads to heme[1] in mammals and chlorophyll[2] in plants. 5ALA is used in photodynamic detection and surgery of cancer.[3][4][5][6] Contents 1 Medical uses 1.1 Cancer diagnosis 1.2 Cancer treatm...

Read more Ameluz Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Aminolevulinic_acid

Recent Ameluz Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Ameluz: (1 result)

Sorted by National Drug Code

• 70621-101 Ameluz 100 mg/g Topical Gel by Biofrontera Inc.

Other drugs which contain Aminolevulinic Acid Hydrochloride or a similar ingredient: (3 results)

• AMINOLEVULINIC ACID
• GLEOLAN Aminolevulinic Acid Hydrochloride
• LEVULAN KERASTICK Aminolevulinic Acid